- Lowers blood glucose levels by facilitating cellular uptake of glucose.
- Stimulates the liver to store glucose as glycogen.
- Enhances the synthesis of proteins, fats, and glycogen.
- Inhibits the breakdown of fat and muscle tissue.
- Facilitates the uptake of glucose into cells for energy production.
- Promotes potassium uptake into cells, which is crucial for cellular functions.
- Examples: Insulin lispro (Humalog), insulin aspart (NovoLog).
- Example: Regular insulin (Humulin R, Novolin R).
- Example: NPH insulin (Humulin N, Novolin N).
- Examples: Insulin glargine (Lantus), insulin detemir (Levemir).
- Example: Insulin degludec (Tresiba).
- Type 1 Diabetes: The body does not produce insulin, so daily administration is essential.
- Type 2 Diabetes: The body does not use insulin properly (insulin resistance) and may not produce enough insulin. Insulin therapy may be needed if other medications do not control blood sugar.
- Hypoglycemia: Too much insulin can cause blood sugar levels to drop too low, leading to dizziness, confusion, and in severe cases, loss of consciousness.
- Weight Gain: Insulin can promote fat storage.
- Injection Site Reactions: Redness, swelling, or pain at the injection site.
- Allergic Reactions: Rare, but possible.
- Fingerstick Blood Tests: Using a glucometer.
- Continuous Glucose Monitoring (CGM): Devices that provide real-time glucose readings.
- Smart Insulin Pens: Devices that track dosing and timing to help manage insulin therapy more effectively.
- Artificial Pancreas Systems: Closed-loop systems that automate insulin delivery based on glucose levels.
- New Formulations: Development of faster-acting insulins and combinations with other diabetes medications.